The technology of R-cube-CE (Rapid, Rare Cell 3D Expansion) was invented by one of the spin-off companies from Academia Sinica, the most prestigious research institution in Taiwan. The company is comprised of Silicon Valley entrepreneurs and experienced scientists and engineers in biology and materials engineering.
R-cube-CE is a rapid 3D culture system for single cell proliferation. It is a clinically verified platform, capable of generating single cell derived organoids within one to four weeks. It outperforms currently available 3D culture technologies in terms of yields, time to form organoids, and easiness of operation. It also demonstrates similar yields and cost structure to 2D culture protocols.
R-cube-CE is ready for drug testing for clinical samples and provides sufficient quantity genomic sample derived from cancer patients. It would be helpful in conducting clinical treatment and in practicing cancer precision medicine and regenerative medicine in translational study.
We welcome collaboration opportunities in forming partnerships with international companies to engage markets in cell therapy, stem cell proliferation, drug screening, preclinical testing, in vitro cell culture and cell bank.